Skip to main content
. 2016 Dec 21;14(2):122–129. doi: 10.1177/1479164116677968

Table 1.

Primer sequences used in pyrosequencing assays.

Region CpG sites Primer sequences
miR-145, assay 1 −189, −175, −148, −112, −109, −106 Forward: GAGATTGGGGAATATATATGAGT
Reverse: [Biotin]-TCTTCTACATCCAACCCCATCTAT
Sequencing: GAGGGTAGTTTTGGG
miR-145, assay 2 −189, −175, −148, −112, −109, −106 Forward: [Biotin]-GGAGATTGGGGAATATATATGAGT
Reverse: AAACCAACTAAAATTCTCTTCTACAT
Sequencing: ATTCTCTTCTACATCCAAC
miR-145, assay 3 −148, −112, −109, −106 Forward: GGTATTTTTTAGGGTAATTGAAGTTT
Reverse: [Biotin]-TCTACATCCAACCCCATCTATAACAA
Sequencing: ATTATTTTTTTTTAGAGTAATAAGT
miR-145, assay 4 −32, −29, −20, −6, +13 Forward: GGGTTGGATGTAGAAGAGAATTTTA
Reverse: [Biotin]-TCCAAAAATCCCCATCTTAACAT
Sequencing: ATTTTAGTTGGTTTTTAGGGATA
miR143HG, assay 5 −106, 79, −31, −26, −16 Forward: TTTTTTTTTAGGGGGTAAAAGTAATATT
Reverse: [Biotin]-CCTAACCACAAAAACCACTCTAC
Sequencing: AGGGGGTAAAAGTAATATTT
miR143HG, assay 6 −31, −26, −16, +46 Forward: GGGGGTGTTTGGGTTAAT
Reverse: [Biotin]-TAAACCCCCCTCCCCTTAAT
Sequencing: TTTGGGAGGGTTTAG
miR143HG, assay 7 −106, 79, −31, −26, −16 Forward: GGTTTTTGGTGGTTGGAGTTAAG
Reverse: [Biotin]-ACCACAAAAACCACTCTACC
Sequencing: AGGGGGTAAAAGTAATATT